Cargando…
Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes
BACKGROUND: Topiramate (TPM) is suggested to be a promising medication for treatment of methamphetamine (METH) dependence, but the molecular basis remains to be elucidated. METHODS: Among 140 METH-dependent participants randomly assigned to receive either TPM (N = 69) or placebo (N = 71) in a previo...
Autores principales: | Niu, Tianhua, Li, Jingjing, Wang, Ju, Ma, Jennie Z., Li, Ming D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733474/ https://www.ncbi.nlm.nih.gov/pubmed/29321746 http://dx.doi.org/10.3389/fpsyt.2017.00271 |
Ejemplares similares
-
Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction
por: Li, Ming D, et al.
Publicado: (2014) -
Topiramate-Induced Lithium Toxicity
por: Khan, Afaque H, et al.
Publicado: (2017) -
Association Between Alexithymia, Social Support, and Duration of Methamphetamine Use Among Male Methamphetamine-Dependent Patients
por: Cui, Shu, et al.
Publicado: (2021) -
Associations of executive function and age of first use of methamphetamine with methamphetamine relapse
por: Mu, Lin-Lin, et al.
Publicado: (2022) -
Treatment Response Prediction and Individualized Identification of Short-Term Abstinence Methamphetamine Dependence Using Brain Graph Metrics
por: Yan, Cui, et al.
Publicado: (2021)